In smaller transactions, ARK sold shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) and CareDx Inc (NASDAQ: CDNA ), and bought shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Veracyte Inc ...

Illumina, a next-generation DNA sequencing company, has called off its plans to buy nascent competitor Pacific Biosciences of California. Some of the banks that helped fuel the fracking boom are ...

Illumina Inc. ILMN reported first-quarter 2025 adjusted earnings per share (EPS) of 97 cents, which topped the Zacks ...

The global Single Cell Analysis Market , valued at US$3.55 billion in 2024, is forecasted to grow at a robust CAGR of 14.7%, ...

Bernstein analyst Eve Burstein maintained a Hold rating on Revvity (RVTY – Research Report) today and set a price target of $120.00. The company’s shares closed last Friday at ...